Glioblastoma Multiforme (GBM) is a devastating disease with a low survival rate and few
efficacious treatment options. The fast growth, late diagnostics, and off-target toxicity of …

Even though substantial advances in understanding glioma pathogenesis have prompted a
more rational design of potential therapeutic strategies, glioblastoma multiforme remains an …

Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis and high
mortality, with no curative treatment to date as limited trafficking across the blood–brain …

Glioblastoma (GBM), a highly aggressive form of brain cancer, is considered one of the
deadliest cancers, and even with the most advanced medical treatments, most affected …

Glioblastoma (GBM) is a highly aggressive and lethal type of brain tumor with complex and
diverse molecular signaling pathways involved that are in its development and progression …

Simple Summary Glioblastoma multiforme (GBM) are among the most lethal tumors. The
highly invasive nature and presence of GBM stem cells, as well as the blood brain barrier …

Glioblastoma (GB) is an aggressive cancer with high microvascular proliferation, resulting in
accelerated invasion and diffused infiltration into the surrounding brain tissues with very low …

Gliomas are the most common type of brain cancer, and among them, glioblastoma
multiforme (GBM) is the most prevalent (about 60% of cases) and the most aggressive type …

Glioblastoma multiforme (GBM) has several distinctive characteristics linked to a poor early-
stage prognosis. The crucial obstacle in the treatment of GBM is the inability of chemo drugs …

Gliomas, and in particular glioblastoma multiforme, are aggressive brain tumors
characterized by a poor prognosis and high rates of recurrence. Current treatment strategies …